A cytochrome P450 monooxygenase involved in the metabolism of fatty acids and their oxygenated derivatives (oxylipins) (PubMed:
7679927, PubMed:
1739747, PubMed:
8914854, PubMed:
10553002, PubMed:
10660572, PubMed:
15611369). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (CPR; NADPH-ferrihemoprotein reductase) (PubMed:
7679927, PubMed:
1739747, PubMed:
8914854, PubMed:
10553002, PubMed:
10660572, PubMed:
15611369). Catalyzes predominantly the oxidation of the terminal carbon (omega-oxidation) of saturated and unsaturated fatty acids, the catalytic efficiency decreasing in the following order: dodecanoic > tetradecanoic > (9Z)-octadecenoic > (9Z,12Z)-octadecadienoic > hexadecanoic acid (PubMed:
10553002, PubMed:
10660572). Acts as a major omega-hydroxylase for dodecanoic (lauric) acid in liver (PubMed:
7679927, PubMed:
1739747, PubMed:
8914854, PubMed:
15611369). Participates in omega-hydroxylation of (5Z,8Z,11Z,14Z)-eicosatetraenoic acid (arachidonate) to 20- hydroxyeicosatetraenoic acid (20-HETE), a signaling molecule acting both as vasoconstrictive and natriuretic with overall effect on arterial blood pressure (PubMed:
10620324, PubMed:
10660572, PubMed:
15611369). Can also catalyze the oxidation of the penultimate carbon (omega-1 oxidation) of fatty acids with lower efficiency (PubMed:
7679927). May contribute to the degradation of saturated very long-chain fatty acids (VLCFAs) such as docosanoic acid, by catalyzing successive omega-oxidations to the corresponding dicarboxylic acid, thereby initiating chain shortening (PubMed:
18182499). Omega- hydroxylates (9R,10S)-epoxy-octadecanoate stereoisomer (PubMed:
15145985). Plays a minor role in omega-oxidation of long-chain 3-hydroxy fatty acids (PubMed:
18065749). Has little activity toward prostaglandins A1 and E1 (PubMed:
7679927).
